MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

Quest Diagnostics Inc

Chiusa

SettoreSettore sanitario

189.48 1.55

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

189.07

Massimo

189.97

Metriche Chiave

By Trading Economics

Entrata

61M

296M

Vendite

109M

2.8B

P/E

Media del settore

21.89

36.442

Rendimento da dividendi

1.68

Margine di Profitto

10.721

Dipendenti

55,000

EBITDA

-37M

451M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+2.11% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

1.68%

3.00%

Utili prossimi

21 ott 2025

Prossima data del Dividendo

20 ott 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

1.9B

20B

Apertura precedente

187.93

Chiusura precedente

189.48

Notizie sul Sentiment di mercato

By Acuity

37%

63%

97 / 371 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bullish Evidence

Quest Diagnostics Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

17 ott 2025, 18:13 UTC

I principali Market Mover

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

17 ott 2025, 17:05 UTC

I principali Market Mover

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

18 ott 2025, 13:30 UTC

Acquisizioni, Fusioni, Takeovers

Deal Expected to Value Unit at Roughly $4B, Sources Say -- WSJ

18 ott 2025, 13:30 UTC

Acquisizioni, Fusioni, Takeovers

Deal Could Be Announced as Soon as Next Week, Sources Say -- WSJ

18 ott 2025, 13:30 UTC

Acquisizioni, Fusioni, Takeovers

Gucci Owner Kering Nears $4 Billion Sale of Beauty Unit to L'Oréal -- WSJ

18 ott 2025, 13:30 UTC

Acquisizioni, Fusioni, Takeovers

Gucci Parent Kering in Talks to Sell Beauty Business to L'Oréal, Sources Say -- WSJ

18 ott 2025, 08:20 UTC

Discorsi di Mercato

Tech, Media & Telecom Roundup: Market Talk

18 ott 2025, 07:00 UTC

Utili

A Growing Nimby Movement Could Upend the Data Center Boom -- Barrons.com

17 ott 2025, 23:25 UTC

Acquisizioni, Fusioni, Takeovers

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17 ott 2025, 22:15 UTC

Discorsi di Mercato

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17 ott 2025, 21:15 UTC

Discorsi di Mercato

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

17 ott 2025, 21:07 UTC

Discorsi di Mercato

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

17 ott 2025, 21:07 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

17 ott 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

17 ott 2025, 20:34 UTC

Discorsi di Mercato

Deere Is Reaching the End of Its Downcycle -- Market Talk

17 ott 2025, 20:27 UTC

Discorsi di Mercato

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

17 ott 2025, 19:46 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

17 ott 2025, 19:45 UTC

Discorsi di Mercato

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

17 ott 2025, 18:45 UTC

Discorsi di Mercato

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

17 ott 2025, 17:51 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

17 ott 2025, 17:51 UTC

Discorsi di Mercato

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

17 ott 2025, 17:44 UTC

Discorsi di Mercato

EQT Seen With Long-Term Growth Opportunities -- Market Talk

17 ott 2025, 17:35 UTC

Discorsi di Mercato

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

17 ott 2025, 16:20 UTC

Discorsi di Mercato
Utili

Tech, Media & Telecom Roundup: Market Talk

17 ott 2025, 16:20 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

17 ott 2025, 16:14 UTC

Discorsi di Mercato

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

17 ott 2025, 16:04 UTC

Discorsi di Mercato

Home Improvement Demand Is Starting to Pick Up -- Market Talk

17 ott 2025, 15:58 UTC

Discorsi di Mercato

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

17 ott 2025, 15:56 UTC

Utili

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

17 ott 2025, 15:43 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

Confronto tra pari

Modifica del prezzo

Quest Diagnostics Inc Previsione

Obiettivo di Prezzo

By TipRanks

2.11% in crescita

Previsioni per 12 mesi

Media 193.5 USD  2.11%

Alto 210 USD

Basso 178 USD

Basato su 13 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Quest Diagnostics Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

13 ratings

5

Acquista

8

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

175.87 / 176.5Supporto e resistenza

A breve termine

Bullish Evidence

A termine intermedio

Strong Bullish Evidence

A lungo termine

Weak Bullish Evidence

Sentiment

By Acuity

97 / 371 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Quest Diagnostics Inc

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
help-icon Live chat